课题基金 / 基金详情

HUMAN IMP DEHYDROGENASE

HUMAN IMP DEHYDROGENASE
人IMP脱氢酶
批准号:
6658599
负责人:
JOHN R SOMOZA
金额:
$14.32万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-03-01 至 2003-02-28

项目摘要

项目成果

JOHN R SOMOZA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Human IMP dehydrogenase (IMPDH) catalyzes the NAD-dependent oxidation of IMP to XMP, making it a key component in the synthesis of guanine nucleotides. Two isoforms of the enzyme exit and these two forms share approximately 84% sequence identity. There is evidence that inhibitors of type II IMPDH are effective antiproliferative agents, and may be useful in controlling some forms on cancer. It has also been shown that inhibitors if IMPDH have immunosuppressive activity. Future efforts to understand and utilize the therapeutic benefits resulting from the inhibition of IMPDH activity would be greatly aided by obtaining the structure of this enzyme.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CRYSTALLOGRAPHIC STUDIES OF CANCER AND INFLAMMATION PROTEIN TARGETS
  • 批准号:
    7598160
  • 项目类别:
  • 资助金额:
    $0.02万
  • 财政年份:
    2007
  • 负责人:
    JOHN R SOMOZA
  • 依托单位:
CRYSTALLOGRAPHIC STUDIES OF CANCER AND INFLAMMATION PROTEIN TARGETS
  • 批准号:
    7370611
  • 项目类别:
  • 资助金额:
    $0.09万
  • 财政年份:
    2006
  • 负责人:
    JOHN R SOMOZA
  • 依托单位:
HUMAN IMP DEHYDROGENASE
  • 批准号:
    6586632
  • 项目类别:
  • 资助金额:
    $14.32万
  • 财政年份:
    2002
  • 负责人:
    JOHN R SOMOZA
  • 依托单位:
HUMAN IMP DEHYDROGENASE
  • 批准号:
    6437550
  • 项目类别:
  • 资助金额:
    $14.32万
  • 财政年份:
    2001
  • 负责人:
    JOHN R SOMOZA
  • 依托单位:
海外基金